NYSE: SCL
STEPAN COCIK 0000094049 · SIC 2840 · Soap & Cleaning Products
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (YELP 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade SCL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Stepan replaces credit facilities with new $500M agreement maturing 2031
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Nov 4, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Income (Unaudited)
(In thousands, except per share amounts)
| Description | Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|---|---|
| Net Sales | 692,154 | 590,284 | 1,980,772 | 1,778,228 |
| Cost of Sales | 604,573 | 519,261 | 1,728,358 | 1,559,857 |
| Gross Profit | 87,581 | 71,023 | 252,414 | 218,371 |
| Operating Expenses: | ||||
| Selling | 13,726 | 11,299 | 40,758 | 38,064 |
| Administrative | 26,607 | 22,864 | 72,123 | 67,079 |
| Research, development and technical services | 15,670 | 14,225 | 47,858 | 43,575 |
| Deferred compensation expense | 37 | 841 | 2,001 | 1,606 |
| 56,040 | 49,229 | 162,740 | 150,324 | |
| Business restructuring (Note 16) | 5,582 | — | 76,127 | — |
| Operating Income | 25,959 | 21,794 | 13,547 | 68,047 |
| Other Income (Expense): | ||||
| Interest, net | (6,344) | (6,815) | (17,037) | (16,426) |
| Other, net (Note 15) | 212 | 1,536 | 1,377 | 3,344 |
| (6,132) | (5,279) | (15,660) | (13,082) | |
| Income (Loss) Before Provision for Income Taxes | 19,827 | 16,515 | (2,113) | 54,965 |
| Provision for Income Taxes | 2,014 | 5,676 | (1,431) | 13,074 |
| Net Income (Loss) | 17,813 | 10,839 | (682) | 41,891 |
| Net Income (Loss) Per Common Share (Note 10): | ||||
| Basic | 0.78 | 0.47 | (0.03) | 1.83 |
| Diluted | 0.78 | 0.47 | (0.03) | 1.83 |
| Shares Used to Compute Net Income (Loss) Per Common Share (Note 10): | ||||
| Basic | 22,906 | 22,875 | 22,897 | 22,869 |
| Diluted | 22,978 | 22,893 | 22,897 | 22,888 |
Condensed Consolidated Balance Sheets (Unaudited)
(Dollars in thousands)
| Description | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | 98,092 | 132,688 |
| Receivables, net | 502,070 | 387,959 |
| Inventories (Note 6) | 340,005 | 298,827 |
| Other current assets | 42,597 | 39,485 |
| Total current assets | 982,764 | 858,959 |
| Property, Plant and Equipment: | ||
| Cost | 2,781,628 | 2,787,036 |
| Less: Accumulated depreciation | (1,648,737) | (1,567,409) |
| Property, plant and equipment, net | 1,132,891 | 1,219,627 |
| Goodwill, net | 91,363 | 92,570 |
| Other intangible assets, net | 34,169 | 39,526 |
| Long-term investments (Note 3) | 14,468 | 21,270 |
| Operating lease assets (Note 7) | 54,588 | 62,494 |
| Other non-current assets | 80,154 | 63,256 |
| Total assets | 2,390,397 | 2,357,702 |
| Liabilities and Equity | ||
| Current Liabilities: | ||
| Current maturities of debt (Note 14) | 292,410 | 285,735 |
| Accounts payable | 315,189 | 261,723 |
| Accrued liabilities | 135,376 | 119,036 |
| Total current liabilities | 742,975 | 666,494 |
| Deferred income taxes | 11,008 | 11,450 |
| Long-term debt, less current maturities (Note 14) | 341,687 | 340,975 |
| Non-current operating lease liabilities (Note 7) | 42,394 | 49,340 |
| Other non-current liabilities | 33,546 | 45,433 |
| Commitments and Contingencies (Note 8) | ||
| Equity: | ||
| Common stock, $1 par value; authorized 60,000,000 shares; 27,470,614 issued shares in 2026 and 27,301,177 issued shares in 2025 | 27,471 | 27,301 |
| Additional paid-in capital | 267,506 | 259,820 |
| Accumulated other comprehensive loss (Note 11) | (140,947) | (138,974) |
| Retained earnings | 1,258,148 | 1,285,752 |
| Less: Common treasury stock, at cost, 4,735,953 shares in 2026 and 4,676,739 shares in 2025 | (193,391) | (189,889) |
| Total equity | 1,218,787 | 1,244,010 |
| Total liabilities and equity | 2,390,397 | 2,357,702 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In thousands)
| Description | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 |
|---|---|---|
| Cash Flows From Operating Activities | ||
| Net income (loss) | (682) | 41,891 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 95,156 | 93,305 |
| Deferred compensation (income) expense | 2,001 | 1,606 |
| Realized and unrealized loss on long-term investments | (991) | (2,008) |
| Stock-based compensation | 5,787 | 4,468 |
| Deferred income taxes | (14,290) | 1,733 |
| Business restructuring | 63,368 | — |
| Other non-cash items | 1,473 | 1,227 |
| Changes in assets and liabilities: | ||
| Receivables, net | (117,986) | (25,308) |
| Inventories | (40,951) | (24,848) |
| Other current assets | (2,931) | (7,409) |
| Accounts payable and accrued liabilities | 62,896 | 6,524 |
| Pension liabilities | 657 | (673) |
| Environmental and legal liabilities | 2,576 | (546) |
| Deferred revenues | (1,444) | (2,071) |
| Net Cash Provided By Operating Activities | 54,639 | 87,891 |
| Cash Flows From Investing Activities | ||
| Expenditures for property, plant and equipment | (75,449) | (87,896) |
| Other, net | 7,978 | 6,878 |
| Net Cash Used In Investing Activities | (67,471) | (81,018) |
| Cash Flows From Financing Activities | ||
| Credit facility borrowings and bank overdrafts, net (Note 14) | 179,474 | 3,582 |
| Credit facility payments (Note 14) | (127,174) | — |
| Other debt borrowings | — | 75,000 |
| Other debt repayments | (45,000) | (48,571) |
| Dividends paid | (26,922) | (26,095) |
| Stock option exercises | 294 | 104 |
| Other, net | (3,444) | (1,760) |
| Net Cash Provided By (Used In) Financing Activities | (22,772) | 2,260 |
| Effect of Exchange Rate Changes on Cash | 1,008 | 9,739 |
| Net Decrease in Cash and Cash Equivalents | (34,596) | 18,872 |
| Cash and Cash Equivalents at Beginning of Period | 132,688 | 99,665 |
| Cash and Cash Equivalents at End of Period | 98,092 | 118,537 |
| Supplemental Cash Flow Information | ||
| Cash payments of income taxes, net of refunds | 16,255 | 4,065 |
| Cash payments of interest | 20,933 | 20,330 |
Amounts as printed on the EDGAR/iXBRL face — (In thousands, except per share amounts); (Dollars in thousands); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗